000 | 02022cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223031208.0 | ||
008 | 150404s2014 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.01.M.Sc.2014.Am.S | ||
100 | 0 | _aAmr Mahmoud Hassan Gad | |
245 | 1 | 0 |
_aSugammadex, a modern day approach for the reversal of neuromuscular relaxation / _cAmr Mahmoud Hassan Gad ; Supervised Ashraf Rady Ahmed Asswa , Dina Zakaria Mohammad Khalaf , Heba Ismail Ahmed Nagy |
246 | 1 | 5 | _aسوجماديكس: النهج الحديث لإنعكاس العقاقير المرخيه العضلات |
260 |
_aCairo : _bAmr Mahmoud Hassan Gad , _c2014 |
||
300 |
_a112 Leaves : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Anesthesia | ||
520 | _aThe formation of this sugammadex/NMBA complex results in a reduction in the amount of free circulating NMBA, leaving the receptor available for binding to Ach .Any degree of neuromuscular block produced by rocuronium or vecuronium can be rapidly and completely reversed without autonomic effects. Because sugammadex is optimized for reversing rocuronium it is most likely to be used in conjunction with this drug. Sugammadex was three times more rapid than edrophonium and it{u2019}s onset time is about 10 times more rapid than neostigmine. Neither atropine nor glycopyrrolate was needed with sugammadex, these patients{u2019} mouths were not as dry as with neostigmine or edrophonium | ||
530 | _aIssued also as CD | ||
653 | 4 | _a NMBA | |
653 | 4 | _a SNARs | |
653 | 4 | _a Sugammadex | |
700 | 0 |
_aAshraf Rady Ahmed Asswa , _esupervisor |
|
700 | 0 |
_aDina Zakaria Mohammad Khalaf , _esupervisor |
|
700 | 0 |
_aHeba Ismail Ahmed Nagy , _esupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSoheir _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c50246 _d50246 |